Riskpilot← Back to searchSign inGet full accessVitrosorb AB
ABActiveOrg 5567826218Per Albin Hanssons Väg 41Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20095-9 employees
Revenue 2024
SEK 10,8M
+15% vs 2023
EBITDA margin
-5.1%
+76% vs 2023
Equity ratio
72.5%
Financial strength
Net profit 2024
SEK -2,4M
+28% vs 2023
| Revenue | SEK 10,8M | +15% |
| EBITDA | SEK -548K | +76% |
| Net profit | SEK -2,4M | +28% |
| Total assets | SEK 9,8M | -12% |
| Equity | SEK 7,1M | -26% |
| Employees | — | — |
Legal name
Vitrosorb AB
Org number
5567826218
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15 maj 2009
Share capital
SEK 1 954 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Lindqvist, Lars Göran i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva utveckling, produktion och försäljning av medicintekniska produkter samt därmed förenlig verksamhet.
Address
Per Albin Hanssons Väg 41
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 279 | 2 256 | 5 351 | 9 383 | 10 824 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −231 | 90 | −275 | −371 | −219 | −423 | −2 992 | −1 317 | −2 288 | −548 |
| Depreciation & amort. | −0 | −6 | −30 | −33 | −34 | −34 | −978 | −966 | −974 | −974 |
| EBIT | −231 | 84 | −305 | −404 | −253 | −457 | −3 970 | −2 283 | −3 262 | −1 522 |
| Net financials | −108 | −108 | −105 | −103 | −104 | −116 | −146 | −116 | −109 | −916 |
| Profit before tax | −340 | −24 | −410 | −507 | 3 | −575 | −4 115 | −2 398 | −3 371 | −2 438 |
| Tax | −0 | −0 | −0 | −0 | −3 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −340 | −24 | −410 | −507 | −360 | −575 | −4 115 | −2 398 | −3 371 | −2 438 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 445 | 5 934 | 5 824 | 7 481 | 9 155 | 10 614 | 12 896 | 14 763 | 11 101 | 9 757 |
| Equity | 1 129 | 4 480 | 4 070 | 6 016 | 7 566 | 7 991 | 10 278 | 12 880 | 9 509 | 7 071 |
| Long-term debt | 1 188 | 1 144 | 1 144 | 1 114 | 1 084 | 2 054 | 1 866 | 1 259 | 651 | 0 |
| Short-term debt | 128 | 310 | 610 | 351 | 504 | 569 | 751 | 625 | 942 | 2 687 |
| Total debt | 1 316 | 1 454 | 1 754 | 1 465 | 1 588 | 2 623 | 2 617 | 1 884 | 1 593 | 2 687 |
EBITDA margin
-5.1%
This company
15.8%
Market median
-132% vs market
20152024
Equity ratio
72.5%
This company
38.2%
Market median
+90% vs market
20152024
Return on equity
-34.5%
This company
18.4%
Market median
-288% vs market
20152024
Net profit margin
-22.5%
This company
8.1%
Market median
-378% vs market
20152024
Asset turnover
1.11×
This company
1.12×
Market median
+1% vs market
20152024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DÅ | Audit | 2020 | — | — |
LG Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Vitrosorb AB 
Vitrosorb Technology ABBoard members of Vitrosorb AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| David Åke Allan Eskilsson | Audit | 0 companies |
| Lars Göran Lindqvist | Chief Executive Officer | 0 companies |
| Lars Håkan Lagerberg | Board of Directors | 0 companies |
| Marcello Gunnar Ugo Grondelli | Board of Directors | 0 companies |
| Michael Stefan Sjösten | Board of Directors | 0 companies |
| Lennart Wilhelm Ljunggren | Board of Directors | 0 companies |
| Anders Johannes Lars Torstensson | Board of Directors | 0 companies |
| Göran Olof Magnus Wikefeldt | Board of Directors | 0 companies |